Joycelynne M Palmer Selected Research

remdesivir

1/2023

Leflunomide Confers Rapid Recovery from COVID-19 and is Coupled with Temporal Immunologic Changes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joycelynne M Palmer Research Topics

Disease

6	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 07/2011
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 06/2009
4	Multiple Myeloma 07/2018 - 01/2014
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2017 - 01/2008
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2015 - 08/2008
2	Infections 01/2023 - 06/2009
2	Neoplasms (Cancer) 01/2023 - 01/2017
2	Lymphoma (Lymphomas) 01/2017 - 12/2014
2	Philadelphia Chromosome 07/2015 - 08/2008
1	COVID-19 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Residual Neoplasm 01/2018
1	Pathologic Complete Response 12/2015
1	Chromosome Aberrations (Chromosome Abnormalities) 07/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2012
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2011
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2011
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2011
1	Thrombotic Microangiopathies 02/2010
1	Disease Progression 10/2007
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2007

Drug/Important Bio-Agent (IBA)

4	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 01/2008
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 02/2010
3	Brentuximab VedotinIBA 12/2015 - 06/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 07/2018
2	plerixafor FDA Link 09/2017 - 01/2014
2	Sirolimus (Rapamycin)FDA Link 02/2016 - 02/2010
2	Tacrolimus (Prograf)FDA LinkGeneric 02/2016 - 02/2010
2	Carmustine (FIVB)FDA Link 12/2014 - 01/2008
2	Yttrium-90IBA 12/2014 - 01/2008
2	Melphalan (Alkeran)FDA LinkGeneric 12/2014 - 01/2008
2	ibritumomab tiuxetan (Zevalin)FDA Link 12/2014 - 01/2008
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2014 - 01/2008
1	remdesivirIBA 01/2023
1	Leflunomide (Arava)FDA LinkGeneric 01/2023
1	VaccinesIBA 01/2023
1	Ifosfamide FDA LinkGeneric 01/2022
1	NivolumabIBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	IceIBA 01/2022
1	pomalidomideIBA 07/2018
1	Lenalidomide (CC 5013)FDA Link 07/2018
1	ixazomibIBA 07/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	daratumumabIBA 01/2018
1	CopperIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Cyclin D1IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 07/2015
1	N 30IBA 10/2011
1	fludarabineIBA 04/2011
1	Busulfan (Busulfex)FDA Link 02/2010
1	SteroidsIBA 06/2009

Therapy/Procedure

10	Cell Transplantation 01/2022 - 08/2008
6	Therapeutics 01/2023 - 10/2007
6	Stem Cell Transplantation 01/2018 - 10/2007
5	Drug Therapy (Chemotherapy) 01/2017 - 01/2008
3	Homologous Transplantation 01/2022 - 06/2012
2	Transplantation 01/2022 - 01/2008
2	Autologous Transplantation 12/2015 - 12/2014
1	Lymphatic Irradiation 01/2022
1	Salvage Therapy 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 12/2015
1	Radioimmunotherapy 03/2012
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 11/2009
1	Hematopoietic Stem Cell Transplantation 06/2009
1	Radiotherapy 01/2008